New York, USA
08042755644
+919673008130
Anti Cancer

Cytosar Injection 1000 mg – Cytarabine 1000 mg in 10 ml | Informational Guide by Primecare Impex

In stockcod not available
Phone Number

08042755644

Please keep 0 before dialling the number.

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Address New York , New York , United States

New York, USA, United States, 1

Description

Cytosar Injection 1000 mg | Cytarabine 1000 mg in 10 ml Information Guide Learn about Cytosar Injection 1000 mg, containing Cytarabine 1000 mg in 10 ml. Explore its clinical use, mechanism, administration overview, safety monitoring, storage, and regulatory documentation guidance. Cytosar Injection 1000 mg – Cytarabine 1000 mg in 10 ml Anticancer Injection Information Cytosar Injection 1000 mg Product Name: Cytosar Injection 1000 mg Generic Name: Cytarabine Strength: Cytarabine 1000 mg in 10 ml Packing Size: 1 Vial Therapeutic Category: Anticancer Medicine / Antineoplastic Agent Dosage Form: Injection Use: Used in selected cancer treatment protocols under specialist medical supervision Cytosar Injection 1000 mg contains Cytarabine, a chemotherapy medicine used in hospital-based oncology and hematology treatment settings. Cytarabine belongs to the antimetabolite class of anticancer medicines and is commonly associated with treatment protocols for certain blood cancers, especially acute leukemia. This injection should only be administered by trained healthcare professionals. It is not suitable for self-use, home use without medical supervision, or non-prescription use. The dose, route, dilution, schedule, and monitoring plan are decided by an oncologist or hematologist based on the patient’s diagnosis, body surface area, treatment protocol, blood counts, kidney/liver function, and overall health condition. Cytosar Injection 1000 mg is used in oncology treatment protocols where Cytarabine is clinically appropriate. Cytarabine is mainly used for induction and maintenance of remission in acute leukemia. It may also be used in certain other leukemia or lymphoma-related treatment plans when prescribed by a specialist. Where Cytarabine May Be Used Acute Myeloid Leukemia Cytarabine is widely known as a key medicine in many AML treatment protocols. It may be used during induction therapy, consolidation therapy, or other protocol-based regimens. Acute Lymphocytic Leukemia In selected treatment protocols, Cytarabine may be included as part of combination chemotherapy. Meningeal Leukemia Certain preservative-free Cytarabine formulations may be used intrathecally in specific cases under strict hospital supervision. Other Hematologic Malignancies Cytarabine may be included in selected specialist-managed regimens for blood-related cancers depending on the patient’s condition and treatment plan. How Cytosar Works Cytarabine is an antimetabolite chemotherapy medicine. It interferes with DNA synthesis in rapidly dividing cells. Cancer cells, especially leukemia cells, divide quickly and depend on DNA replication for growth and survival. After entering the body, Cytarabine is converted inside cells into its active form. This active form blocks DNA polymerase activity and interferes with DNA chain formation. As a result, rapidly dividing cancer cells are unable to multiply properly, which helps reduce cancer cell growth as part of a planned chemotherapy regimen. Cytosar Injection 1000 mg should be administered only by trained healthcare professionals in a hospital, cancer center, or specialist-supervised clinical environment. Depending on the formulation and treatment protocol, Cytarabine may be administered by: Intravenous injection Intravenous infusion Subcutaneous injection Intrathecal administration, only when the correct preservative-free formulation is used and prescribed The exact dose is not fixed for every patient. It depends on: Type of cancer Stage and treatment protocol Body surface area Age and body weight Blood count status Liver and kidney function Previous chemotherapy history Combination medicines being used Specialist treatment plan Why Choose Primecare Impex Primecare Impex provides structured medicine information support for international healthcare-related enquiries. The focus is on product profile clarity, documentation awareness, and responsible communication for regulated pharmaceutical products. Primecare Impex Highlights Pharmaceutical exporter from India Product information support for oncology medicines Focus on regulated medicine documentation Clear product profile details Professional communication support Guidance on packaging, strength, and product identity Compliance-aware approach for destination country requirements Contact Primecare Impex – Pharmaceutical Exporter from India Company Name: Primecare Impex Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130 Cytosar Injection 1000 mg is an anticancer injection containing Cytarabine 1000 mg in 10 ml. 2. What is the use of Cytarabine 1000 mg injection? Cytarabine is used in selected chemotherapy protocols, especially for acute leukemia treatment under specialist supervision. 3. Is Cytosar Injection 1000 mg used for cancer? Yes, it is an anticancer medicine used in specific leuke

Keywords

Other Products

view all

6814772a5d263414004dd4a4 Card 2

product image
Anti Cancer

Docepar Injection 80 mg, 120 mg & 20 mg – Docetaxel Injection Supplier from India | Primecare Impex Docepar Injection contains Docetaxel, an anti-cancer medicine used in chemotherapy treatment plans. Available in 80 mg/2 ml, 20 mg/0.5 ml and 120 mg/3 ml vial strengths. Contact Primecare Impex, pharmaceutical exporter from India. Docepar Injection – Docetaxel Injection 80 mg/2 ml, 20 mg/0.5 ml & 120 mg/3 ml for Oncology Care Understanding Docepar Injection Product Name: Docepar Injection Generic Composition: Docetaxel Injection Available Strengths: Docepar Injection 20 mg/0.5 ml Docepar Injection 80 mg/2 ml Docepar Injection 120 mg/3 ml Packing Size: 1 Vial Therapeutic Category: Anti-cancer Medicine / Oncology Medicine Dosage Form: Injection Route of Use: Intravenous infusion under medical supervision Use: Anti-cancer medicine used as part of chemotherapy treatment plans Docepar Injection is a Docetaxel-based chemotherapy medicine used in oncology treatment. Docetaxel belongs to the taxane class of anti-cancer medicines and is used by healthcare professionals in the management of several cancer conditions depending on the patient’s diagnosis, treatment stage, body surface area, previous therapy, and oncologist’s prescription. Docepar Injection is available in multiple strengths, including 20 mg/0.5 ml, 80 mg/2 ml and 120 mg/3 ml, allowing oncology teams to select the appropriate vial strength according to the prescribed chemotherapy dose. It is intended only for hospital, cancer-care center, chemotherapy daycare, or licensed clinical use. Docetaxel Injection may be used in treatment plans for different types of cancer as decided by an oncologist. It is commonly associated with oncology protocols for: Breast cancer Non-small cell lung cancer Prostate cancer Gastric cancer Head and neck cancer The exact use depends on the patient’s condition, previous treatment history, cancer type, stage of disease, and the treating doctor’s clinical decision. How Docepar Injection Works Docepar Injection contains Docetaxel, a taxane anti-cancer agent. Docetaxel works by interfering with microtubule function inside cancer cells. Microtubules are important for cell division. By stabilizing microtubules and preventing their normal breakdown, Docetaxel disrupts cancer cell division and slows the growth of rapidly multiplying cancer cells. Because chemotherapy medicines can also affect normal fast-dividing cells, patients may experience side effects. This is why Docetaxel therapy requires blood tests, medical review, and monitoring during the treatment cycle. Docepar Injection 20 mg/0.5 ml Docepar Injection 80 mg/2 ml Docepar Injection 120 mg/3 ml Composition should be checked as Docetaxel Injection with the required vial strength. Docetaxel Injection is a prescription oncology medicine. It should be used only in a licensed medical or oncology setup. Docetaxel Injection exporter from India Docepar Injection supplier from India Oncology medicine exporter Primecare Impex Anti-cancer injection supplier from India Chemotherapy medicine export service Docetaxel Injection 80 mg vial supplier Docepar Injection 120 mg vial information Prescription oncology medicine exporter What is Docepar Injection? Docepar Injection is a Docetaxel-based anti-cancer medicine used in chemotherapy treatment under oncologist supervision. The packing size is 1 vial. Yes, it contains Docetaxel, an anti-cancer medicine used in oncology treatment protocols. What cancers is Docetaxel used for? Docetaxel may be used in treatment plans for breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancer, depending on the doctor’s prescription. Why Choose Primecare Impex? Primecare Impex is a pharmaceutical exporter, supplier, and distributor from India supporting international inquiries for prescription oncology medicines, including Docetaxel Injection products such as Docepar Injection. Primecare Impex focuses on: Oncology medicine export support Product availability assistance Documentation support Export packing guidance Prescription medicine handling awareness Country-wise shipment coordination Professional communication for healthcare-related inquiries All prescription medicines are supplied according to applicable regulatory requirements, documentation, and buyer eligibility. Contact Primecare Impex – Pharmaceutical Exporter from India Company Name: Primecare Impex Business Type: Exporter | Supplier | Distributor Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130 For Docepar Injection 20 mg/0.5 ml, 80 mg/2 ml or 120 mg/3 ml product inquiries, contact Primecare Impex with required strength, quantity, destination country, and documentation requirement. Looking for Docepar Injection 80 mg, 120 mg or 20 mg product information? Contact Primecare Impex for Docetaxel Injection availability, export documentat

6814772a5d263414004dd4a4 Card 2

product image
Anti Cancer

Cytosar Injection 1000 mg | Cytarabine 1000 mg in 10 ml Information Guide Learn about Cytosar Injection 1000 mg, containing Cytarabine 1000 mg in 10 ml. Explore its clinical use, mechanism, administration overview, safety monitoring, storage, and regulatory documentation guidance. Cytosar Injection 1000 mg – Cytarabine 1000 mg in 10 ml Anticancer Injection Information Cytosar Injection 1000 mg Product Name: Cytosar Injection 1000 mg Generic Name: Cytarabine Strength: Cytarabine 1000 mg in 10 ml Packing Size: 1 Vial Therapeutic Category: Anticancer Medicine / Antineoplastic Agent Dosage Form: Injection Use: Used in selected cancer treatment protocols under specialist medical supervision Cytosar Injection 1000 mg contains Cytarabine, a chemotherapy medicine used in hospital-based oncology and hematology treatment settings. Cytarabine belongs to the antimetabolite class of anticancer medicines and is commonly associated with treatment protocols for certain blood cancers, especially acute leukemia. This injection should only be administered by trained healthcare professionals. It is not suitable for self-use, home use without medical supervision, or non-prescription use. The dose, route, dilution, schedule, and monitoring plan are decided by an oncologist or hematologist based on the patient’s diagnosis, body surface area, treatment protocol, blood counts, kidney/liver function, and overall health condition. Cytosar Injection 1000 mg is used in oncology treatment protocols where Cytarabine is clinically appropriate. Cytarabine is mainly used for induction and maintenance of remission in acute leukemia. It may also be used in certain other leukemia or lymphoma-related treatment plans when prescribed by a specialist. Where Cytarabine May Be Used Acute Myeloid Leukemia Cytarabine is widely known as a key medicine in many AML treatment protocols. It may be used during induction therapy, consolidation therapy, or other protocol-based regimens. Acute Lymphocytic Leukemia In selected treatment protocols, Cytarabine may be included as part of combination chemotherapy. Meningeal Leukemia Certain preservative-free Cytarabine formulations may be used intrathecally in specific cases under strict hospital supervision. Other Hematologic Malignancies Cytarabine may be included in selected specialist-managed regimens for blood-related cancers depending on the patient’s condition and treatment plan. How Cytosar Works Cytarabine is an antimetabolite chemotherapy medicine. It interferes with DNA synthesis in rapidly dividing cells. Cancer cells, especially leukemia cells, divide quickly and depend on DNA replication for growth and survival. After entering the body, Cytarabine is converted inside cells into its active form. This active form blocks DNA polymerase activity and interferes with DNA chain formation. As a result, rapidly dividing cancer cells are unable to multiply properly, which helps reduce cancer cell growth as part of a planned chemotherapy regimen. Cytosar Injection 1000 mg should be administered only by trained healthcare professionals in a hospital, cancer center, or specialist-supervised clinical environment. Depending on the formulation and treatment protocol, Cytarabine may be administered by: Intravenous injection Intravenous infusion Subcutaneous injection Intrathecal administration, only when the correct preservative-free formulation is used and prescribed The exact dose is not fixed for every patient. It depends on: Type of cancer Stage and treatment protocol Body surface area Age and body weight Blood count status Liver and kidney function Previous chemotherapy history Combination medicines being used Specialist treatment plan Why Choose Primecare Impex Primecare Impex provides structured medicine information support for international healthcare-related enquiries. The focus is on product profile clarity, documentation awareness, and responsible communication for regulated pharmaceutical products. Primecare Impex Highlights Pharmaceutical exporter from India Product information support for oncology medicines Focus on regulated medicine documentation Clear product profile details Professional communication support Guidance on packaging, strength, and product identity Compliance-aware approach for destination country requirements Contact Primecare Impex – Pharmaceutical Exporter from India Company Name: Primecare Impex Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130 Cytosar Injection 1000 mg is an anticancer injection containing Cytarabine 1000 mg in 10 ml. 2. What is the use of Cytarabine 1000 mg injection? Cytarabine is used in selected chemotherapy protocols, especially for acute leukemia treatment under specialist supervision. 3. Is Cytosar Injection 1000 mg used for cancer? Yes, it is an anticancer medicine used in specific leuke

6814772a5d263414004dd4a4 Card 2

product image
Anti Cancer

Cytaneon Injection 1000 mg – Cytarabine 1000 mg/10 ml Anticancer Injection Information | Primecare Impex Learn about Cytaneon Injection 1000 mg, containing Cytarabine 1000 mg/10 ml, an anticancer medicine used in leukemia treatment protocols under specialist medical supervision. Explore indications, mechanism, administration guidance, safety monitoring, storage, documentation, and Primecare Impex contact details. Cytaneon Injection 1000 mg – Cytarabine 1000 mg/10 ml Anticancer Injection for Oncology Treatment Support Product Profile: Understanding Cytaneon Injection 1000 mg Cytaneon Injection 1000 mg contains Cytarabine 1000 mg/10 ml, an anticancer chemotherapy medicine used in oncology care. Cytarabine belongs to the antimetabolite class of medicines and is mainly used in treatment protocols for blood cancers such as acute leukemia, as decided by an oncologist. Cytaneon Injection is not a general-use medicine and should never be self-administered. It must be handled, prescribed, prepared, and administered only by trained healthcare professionals in a hospital, oncology center, or licensed medical setting. Product Profile: Understanding Cytaneon Injection 1000 mg Cytaneon Injection 1000 mg contains Cytarabine 1000 mg/10 ml, an anticancer chemotherapy medicine used in oncology care. Cytarabine belongs to the antimetabolite class of medicines and is mainly used in treatment protocols for blood cancers such as acute leukemia, as decided by an oncologist. Cytaneon Injection is not a general-use medicine and should never be self-administered. It must be handled, prescribed, prepared, and administered only by trained healthcare professionals in a hospital, oncology center, or licensed medical setting. Cytarabine is used in oncology treatment plans where doctors require an antimetabolite chemotherapy agent. It is commonly associated with leukemia treatment protocols, especially acute myeloid leukemia and other acute leukemia regimens as determined by a specialist. The use of Cytaneon Injection 1000 mg depends on several clinical factors, including: Patient diagnosis Cancer type and stage Body surface area and overall health condition Kidney and liver function Blood count status Previous chemotherapy history Combination medicines used in the protocol Hospital or oncology-center treatment guidelines Cytaneon Injection should only be used when prescribed by a qualified oncologist. Patients should not use this medicine without proper medical assessment, prescription, and monitoring. 2. Mechanism of Action: How Cytaneon Injection Works Cytaneon Injection contains Cytarabine, an antimetabolite chemotherapy medicine. Cytarabine works by interfering with DNA synthesis in rapidly dividing cells. Cancer cells grow and divide quickly, and Cytarabine helps slow or stop this abnormal cell multiplication as part of a planned chemotherapy regimen. In simple words, Cytarabine affects the ability of cancer cells to copy their genetic material during cell division. This makes it useful in specific blood cancer treatment protocols where rapidly dividing abnormal cells need to be controlled. Because it can also affect normal fast-growing cells, careful monitoring is required. This is why blood tests, infection monitoring, liver function checks, kidney function checks, and specialist supervision are important during treatment. Cytaneon Injection 1000 mg is administered only by trained healthcare professionals. The exact dose, route, dilution, infusion duration, and treatment schedule must be decided by the treating oncologist. Cytarabine may be used through different routes depending on the prescribed treatment protocol, such as: Intravenous injection or infusion Subcutaneous administration in selected regimens Intrathecal use only when a suitable preservative-free preparation is prescribed and administered by specialists Why Choose Primecare Impex Primecare Impex is an India-based pharmaceutical exporter, supplier, and distributor providing product information and regulated medicine supply support for international requirements. Why customers contact Primecare Impex: Product information support Export documentation support Oncology medicine sourcing guidance Professional communication India-based pharmaceutical supply network Support for country-wise documentation requirements Assistance with product details, packing, and availability updates Primecare Impex supports responsible medicine supply and recommends that all anticancer medicines be used only under proper medical prescription and supervision. Contact Primecare Impex – Pharmaceutical Exporter from India Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130 Cytarabine 1000 mg injection product information Cytarabine 1000 mg/10 ml injection details Cytaneon Injection 1000 mg information Cytarabine injection for leuke